These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 2561459)
1. PAF-acether, superoxide anion and beta-glucuronidase as parameters of polymorphonuclear cell activation associated with cardiac surgery and cardiopulmonary bypass. Hoshikawa-Fujimura AY; Auler Júnior JO; Da Rocha TR; Brandizzi LI; Pascual JM; Chamone DA; Jatene AD Braz J Med Biol Res; 1989; 22(9):1077-82. PubMed ID: 2561459 [TBL] [Abstract][Full Text] [Related]
4. The effect of leukocyte reduction filters on inflammatory mediator release during coronary artery bypass grafting. Bartkowiak M; Bugajski P; Siminiak T; Kalawski R Kardiol Pol; 2013; 71(9):945-50. PubMed ID: 24065423 [TBL] [Abstract][Full Text] [Related]
5. IgA immune aggregates stimulate platelet-activating factor and superoxide anion production by human neutrophils. A comparison with IgG aggregates. Hernando P; Egido J; de Nicolas R; Gonzalez E Lipids; 1991 Dec; 26(12):1231-5. PubMed ID: 1668120 [TBL] [Abstract][Full Text] [Related]
6. Effect of the Ca2+ antagonist nifedipine on the release of platelet-activating factor (PAF-acether), slow-reacting substance and beta-glucuronidase from human neutrophils. Jouvin-Marche E; Cerrina J; Coëffier E; Duroux P; Benveniste J Eur J Pharmacol; 1983 Apr; 89(1-2):19-26. PubMed ID: 6134631 [TBL] [Abstract][Full Text] [Related]
7. Measurement of ionized cytoplasmic calcium mobilization with the photoprotein aequorin in human polymorphonuclear leukocytes activated by platelet activating factor (PAF). Del Maschio A; Albors M; Evangelista V; Bucchi F; Bertelé V; Cerletti C; de Gaetano G J Lipid Mediat; 1989; 1(1):25-36. PubMed ID: 2562430 [TBL] [Abstract][Full Text] [Related]
8. Differential responsiveness of human neutrophils to the autocrine actions of 1-O-alkyl-homologs and 1-acyl analogs of platelet-activating factor. Pinckard RN; Showell HJ; Castillo R; Lear C; Breslow R; McManus LM; Woodard DS; Ludwig JC J Immunol; 1992 Jun; 148(11):3528-35. PubMed ID: 1316919 [TBL] [Abstract][Full Text] [Related]
9. Platelet modulation of neutrophil superoxide anion production. Moon DG; van der Zee H; Weston LK; Gudewicz PW; Fenton JW; Kaplan JE Thromb Haemost; 1990 Feb; 63(1):91-6. PubMed ID: 2160133 [TBL] [Abstract][Full Text] [Related]
10. Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes. Jouvin-Marche E; Ninio E; Beaurain G; Tence M; Niaudet P; Benveniste J J Immunol; 1984 Aug; 133(2):892-8. PubMed ID: 6736649 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of platelet-activating factor from human polymorphonuclear leukocytes: regulation and pharmacological approaches. Sánchez Crespo M; Alonso F; García Gil M; Gómez-Cambronero J; Nieto ML Int J Tissue React; 1985; 7(5):345-9. PubMed ID: 2997066 [TBL] [Abstract][Full Text] [Related]
13. Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events, and leukotriene B4 metabolism. Sisson JH; Prescott SM; McIntyre TM; Zimmerman GA J Immunol; 1987 Jun; 138(11):3918-26. PubMed ID: 3035016 [TBL] [Abstract][Full Text] [Related]
14. IL-1-induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells. Role of platelet-activating factor. Breviario F; Bertocchi F; Dejana E; Bussolino F J Immunol; 1988 Nov; 141(10):3391-7. PubMed ID: 3263425 [TBL] [Abstract][Full Text] [Related]
15. Cardiopulmonary bypass renders patients at risk for multiple organ failure via early neutrophil priming and late neutrophil disability. Partrick DA; Moore EE; Fullerton DA; Barnett CC; Meldrum DR; Silliman CC J Surg Res; 1999 Sep; 86(1):42-9. PubMed ID: 10452867 [TBL] [Abstract][Full Text] [Related]
16. Adenosine inhibits platelet-activating factor, but not tumour necrosis factor-alpha-induced priming of human neutrophils. Stewart AG; Harris T Immunology; 1993 Jan; 78(1):152-8. PubMed ID: 8382188 [TBL] [Abstract][Full Text] [Related]
17. Involvement of leukotriene B4 and platelet-activating factor in cytokine priming of human polymorphonuclear leucocytes. Stewart AG; Harris T; De Nichilo M; Lopez AF Immunology; 1991 Feb; 72(2):206-12. PubMed ID: 1849872 [TBL] [Abstract][Full Text] [Related]
18. Exercise- and allergen-induced asthma do not change the production of Paf-acether by neutrophils and platelets. Lurie A; Dessanges JF; Delautier D; Coëffier E; Chignard M; Crémer GA; Benveniste J; Marsac J; Lockhart A Bull Eur Physiopathol Respir; 1987; 23(4):347-51. PubMed ID: 3690021 [TBL] [Abstract][Full Text] [Related]
19. Neutrophil chemiluminescence and superoxide production in patients with rheumatoid arthritis: the effect of zymosan, phorbol myristate acetate and platelet-activating factor. Chou CT; Shaio MF; Chang FY; Chang ML Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):281-8. PubMed ID: 1667989 [TBL] [Abstract][Full Text] [Related]
20. Biosynthesis of paf-acether. X. Phorbol myristate acetate-induced paf-acether biosynthesis and acetyltransferase activation in human neutrophils. Leyravaud S; Bossant MJ; Joly F; Bessou G; Benveniste J; Ninio E J Immunol; 1989 Jul; 143(1):245-9. PubMed ID: 2732470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]